Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Nasal Spray Contract Manufacturing

Metered-dose nasal sprays, nasal drops and saline sprays made under your brand by GMP-licensed manufacturers in India.

In a nasal spray, the pump is part of the product

With a tablet, the formula is the product. With a nasal spray, the pump and actuator matter as much as the liquid: they decide the droplet size, how much drug each spray delivers and how the spray reaches the nose. Two sprays with the same formula can perform differently with different pumps.

That is why regulators ask for spray characterisation data as well as a Certificate of Analysis: droplet size distribution, spray pattern, plume geometry, dose per spray and priming. For generic nasal sprays in the US, the FDA's product-specific guidances set out which laboratory tests are needed to show bioequivalence, and for some suspension sprays they may also call for pharmacokinetic or clinical studies.

Nasal sprays are filled and crimped on specialised lines with validated pumps, so only some formulation plants offer them. We shortlist from those.

Tell us this to get a quote

  • Molecule(s) and dose per spray
  • Solution or suspension
  • Preserved or preservative-free
  • Number of sprays per bottle
  • Target market(s)
  • Bottle, pump and pack
  • Annual volume and first-order quantity
  • Your own formula and dossier, or the manufacturer's

What to check in a nasal spray manufacturer

Pump and actuator

Ask which pump is used, who supplies it and what documentation the supplier provides. Changing the pump after registration usually needs new data and a variation.

Spray characterisation

Droplet size distribution, spray pattern, plume geometry and dose per spray, tested with the registered pump at the start and end of shelf life.

Preservative or preservative-free

Many multi-dose sprays contain benzalkonium chloride. Preservative-free sprays need pumps designed to keep microbes out, and more microbial testing.

Approvals for your market

WHO-GMP and a CoPP for most emerging markets; for regulated markets, GMP evidence your regulator accepts, such as an EU GMP certificate, a US FDA inspection, or MHRA or TGA clearance.

Stability in the device

Stability tested in the final bottle and pump, stored upright and inverted, with in-use testing across the number of sprays on the label.

Dose uniformity

For suspension sprays such as fluticasone or mometasone, check that the dose stays uniform from the first spray to the last after shaking.

Common nasal spray products

Product typeExamplesWatch for
Corticosteroid suspensionFluticasone propionate, mometasone furoate, budesonide; azelastine with fluticasoneDose uniformity, particle size, bioequivalence data
Antihistamine solutionAzelastine, olopatadineTaste, spray characterisation
Decongestant solutionOxymetazoline, xylometazolinePreservative, separate children's strengths
Systemic or emergency useSumatriptan, naloxone, desmopressinOften single-dose devices (sumatriptan, naloxone); higher regulatory bar
Saline and seawater spraysIsotonic and hypertonic salineMay be a medical device rather than a medicine in some markets

Requirements for generic nasal sprays differ between markets. We check what your regulator expects before you commit to a site.

How it works with PharmaTradz

1
Brief

You send the product, form, market and volume.

2
Shortlist with approvals

Two or three plants that already make that form, with their approvals and country of manufacture. Names under a confidential disclosure agreement when the requirement is firm.

3
Samples and development

Samples of an existing product, or development and stability batches with the chosen pump for a new one, including spray characterisation.

4
Artwork and registration

Your brand, artwork and pack, and the dossier or product file your market needs.

5
Commercial batches

Production and release with a batch-wise Certificate of Analysis and spray test results. Third-party pre-shipment inspection on request.

6
Repeat supply

Scheduled batches with the same site, materials and documents.

Problems we see most often

Pump changed after registration

A cheaper or unavailable pump is swapped in, and spray performance no longer matches the registered data. Fix the pump in the supply agreement.

Clogging and uneven sprays

Crystals form at the tip or a suspension settles, so sprays become weak or irregular. Ask for in-use test results across the full number of sprays.

Damage in transit

Actuators crack or bottles leak in air freight. Check the closure, the protective cap and the shipper, not just the liquid.

Have a nasal spray product in mind?

Send the molecule, dose per spray, market and annual volume. We will tell you which manufacturers fit and what data they hold.

Send your requirement Talk to our team

Frequently Asked Questions

A licensed manufacturer prepares your formula, fills it into bottles fitted with metered pumps and packs it under your brand, while you handle registration, marketing and distribution, with dossier support from the manufacturer.

Laboratory spray characterisation: droplet size distribution, spray pattern, plume geometry, dose per spray and priming. For some suspension sprays, regulators such as the US FDA may also ask for pharmacokinetic or clinical studies. Requirements vary by market.

Yes, using multi-dose pumps designed to stop microbial contamination, or single-dose devices. Preservative-free products need more microbial testing and the right pump from the start.

It depends on the product and the fill volume. Common multi-dose packs give roughly 50 to 200 metered sprays, and the label claim has to be backed by in-use testing.

Not always. In the EU and several other markets plain saline sprays are regulated as medical devices rather than medicines, while in India saline nasal drops are licensed as drugs, so check the classification in your market before planning registration.

Yes. In India your company is named on the label as the marketer, alongside the manufacturer. As marketer you share responsibility with the manufacturer for quality and regulatory compliance, and you need a written agreement with it (Drugs Rules, 1945, rules 84D and 84E, in force since 1 March 2021). In export markets, that market's labelling and licence-holder rules apply.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us